Japanese Primary Prevention of Atherosclerosis With Aspirin for Diabetes - JPAD


Although aspirin is routinely used in patients with diabetes and increased cardiovascular risk, there are limited data from clinical trials on this issue. Accordingly, the JPAD trial sought to evaluate the effect of low-dose aspirin on cardiovascular outcomes in patients with type 2 diabetes mellitus.